Why is Remus Pharma. falling/rising?

As of 27-Jun, Remus Pharmaceuticals Ltd is experiencing a price increase, with its current price at 1,999.75, reflecting a rise of 40.3 or 2.06%. The stock has outperformed its sector today by 1.18%, and there has been a notable increase in investor participation, with delivery volume rising by 114.69% against the 5-day average. In terms of performance over the past week, the stock has gained 7.42%, although it has seen a slight decline of 0.04% over the past month. The stock is currently above its 5-day, 20-day, and 50-day moving averages, indicating a positive short-term trend, despite being below its 100-day and 200-day moving averages. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader market context shows that while Remus Pharmaceuticals has outperformed the sector in the short term, it has underperformed against the benchmark Sensex over the year-to-date, with a decline of 19.93% compared to the Sensex's gain of 8.43%. In the past week, however, the stock's performance has been strong relative to the benchmark, suggesting a potential recovery or positive sentiment among investors. Overall, the stock's recent upward movement appears to be driven by increased trading activity and short-term gains, despite its longer-term challenges.